Goldschmidt, Siri
Schmidt, Martina E.
Rosenberger, Friederike
Wiskemann, Joachim
Steindorf, Karen
Funding for this research was provided by:
Nationales Centrum für Tumorerkrankungen Heidelberg
Deutsches Krebsforschungszentrum (DKFZ)
Article History
Received: 24 August 2023
Accepted: 18 December 2023
First Online: 3 January 2024
Declarations
:
: All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study. The BENEFIT trial is registered at ExternalRef removed: NCT02999074, and approval was granted in 2015 by the ethics committee of the Medical Faculty of Heidelberg.
: Informed consent was obtained from all individual participants included in the study.
: Informed consent, entailing the consent for publication of the collected data, was obtained from all individual participants included in the study.
: Dr. Steindorf reports personal fees from Adviva Heidelberg, Germany, personal fees from Swiss Group for Clinical Research, Switzerland, personal fees from Pierre Fabre, Freiburg, Germany, personal fees from Breast Cancer Center Unna, Germany, personal fees from Audi Health Insurance, Germany, personal fees from Murgpark Fitness Company, Germany, outside the submitted work.